Stock IGMS IGM BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages IGM Biosciences, Inc.

Equities

IGMS

US4495851085

Market Closed - Nasdaq
Other stock markets
 04:00:01 2024-05-31 pm EDT 		5-day change 1st Jan Change
8.31 USD -4.59% Intraday chart for IGM Biosciences, Inc. -12.98% -.--%
May. 09 RBC Cuts Price Target on IGM Biosciences to $20 From $21, Keeps Outperform, Speculative Risk MT
May. 08 Earnings Flash (IGMS) IGM BIOSCIENCES Posts Q1 Collaboration Revenue $497,000 MT

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
IGM Biosciences to Present at the Jefferies Healthcare Conference
Treatment.com AI Inc. (TRUE.CN) Advances AI in Healthcare with Strategic Moves
RBC Cuts Price Target on IGM Biosciences to $20 From $21, Keeps Outperform, Speculative Risk
Earnings Flash (IGMS) IGM BIOSCIENCES Posts Q1 Collaboration Revenue $497,000
IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update
IGM Biosciences, Inc. Provides Revenue Guidance for the Second Quarter and Full Year 2024
IGM Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
IGM Biosciences to Present at the 2024 RBCCM Global Healthcare Conference
IGM Biosciences, Sanofi Narrow Partnership to Focus on Potential Immunology and Inflamation Targets
IGM Biosciences Announces Refocusing of Sanofi Collaboration
IGM Biosciences, Inc. Announces Refocusing of Sanofi Collaboration
IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum
North American Morning Briefing : Stocks Set for -2-
HC Wainwright Adjusts IGM Biosciences Price Target to $12 From $7, Maintains Neutral Rating
Earnings Flash (IGMS) IGM BIOSCIENCES Reports Q4 Revenue $651,000
IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Igm Biosciences, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
IGM Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
MEDIVIR AB - YEAR-END REPORT JANUARY - DECEMBER 2023
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IGMS Stock
  4. News IGM Biosciences, Inc.
  5. Other languages